ESG Report 2025

8.4.1 Management of Publicity and Promotion In terms of publicity and promotion management, The United Laboratories implements unified planning and compliance review for all promotional materials. Given that the Company's core products are mostly prescription drugs, we strictly comply with the regulation that prescription drug advertisements shall not be published in mass media, and we do not issue any prescription drug advertisements through public media. All drug advertisements and promotional materials are independently designed by the Company's internal Brand and Culture Department, and are released after review by the Marketing Department and the Legal Compliance Department. If a third party is commissioned for design, the design plan and content must also be reviewed by the Group's Corporate Culture and Publicity Department and Legal Centre, ensuring the accuracy and legality of promotional content from the source. Regarding the use of materials, we insist on using original works or materials for which usage rights have been legally obtained, and we explicitly stipulate intellectual property ownership and infringement liability in contracts with advertising producers to mitigate intellectual property risks. In terms of distribution channel management, the Group implements unified registration and filing management for all online platforms bearing the words “The United Laboratories” or having an official promotional nature. Any subsidiary establishing a platform must obtain approval from the Group's Brand Culture Department, following the principle of “no registration unless necessary”. In principle, only one official account may be registered on the same platform. Platform administrators and review responsible persons must strictly verify the authenticity and legality of published information. Each subsidiary must establish an information release review process, clearly designate review responsible persons, and report important content to the Group's Brand Culture Department for record. To ensure that all externally published information complies with regulatory requirements, the Group has established a compliance review system for information release. All documents for external release (including promotional materials, official website articles, notices and announcements) must be submitted to the Compliance Department for review through the “Information Release Review Application” process before release. The review covers drug business compliance, advertising legality, unfair competition, personal information protection, intellectual property infringement risks, etc. Documents that have not been reviewed or have failed the review shall not be released. Externally released information must complete the “Information Release Review Registration Form” and may only be released after approval by the review responsible person, ensuring the truthfulness, accuracy and compliance of the information content. In terms of partner management, the Group strictly verifies the qualifications and credit records of distributors or advertising partners when selecting them, and excludes those with adverse records from cooperation. The contracts signed with distributors include an integrity cooperation agreement, specifying the obligations of both parties in areas such as anti-commercial bribery and compliance promotion, ensuring that the cooperation process is compliant and controllable. 8.4.2 Training and Inspection To ensure the implementation of all compliance requirements, The United Laboratories has established a routine marketing compliance training and inspection mechanism. The Group's sales team covers the entire country. The recruitment, performance appraisal, training and occupational safety management of sales personnel are centrally managed and supervised by the Group's headquarters, ensuring that all managers and front-line promotion personnel receive the necessary training, thereby achieving a uniform professional standard and providing customers with the highest quality service. The Group conducts a full-staff centralised training at least once every two years, focusing on the “Advertising Law”, the “Drug Administration Law” and the Company's internal compliance systems. Through internal knowledge bases, case notifications and other means, we continuously strengthen employees' compliance awareness. During the Reporting Period, responsible marketing training covered all sales personnel, with a total of 5,200 individuals trained and a cumulative training duration of 4,200 hours. In terms of compliance inspections, the Compliance Department, in accordance with the “Compliance Unannounced Inspection System”, regularly conducts systematic reviews of promotional activities carried out by the Company and commissioned sales personnel in various regions, with inspection times not disclosed in advance. Inspection methods include accompanying sales personnel in their daily work, on-site office inspections, logging into the OA platform to review work reports, interviews or questionnaire surveys. The inspection content covers promotional conduct at academic events, event notifications, interactions with relevant organisational personnel, etc. After the inspection, a “Compliance Inspection Report” is prepared. The inspected department must submit a corrective action report within seven working days, and the Compliance Department follows up on the implementation of corrective actions. In terms of expense control, the Compliance Department conducts annual random audits of financial vouchers, reviewing whether promotion fee payments comply with Company standards in terms of “legality, authenticity and reasonableness”, and eliminating issues such as “fictitious expenses or cash extraction”. The unannounced inspection checklist for the Group's sales personnel is shown in the table below. 70 The United Laboratories International Holdings Limited 2025 Environmental, Social and Governance Report